• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SDF1 过表达间充质干细胞衍生的外泌体抑制心肌梗死后小鼠缺血心肌细胞凋亡并促进心脏内皮微血管再生。

Exosomes derived from SDF1-overexpressing mesenchymal stem cells inhibit ischemic myocardial cell apoptosis and promote cardiac endothelial microvascular regeneration in mice with myocardial infarction.

机构信息

Department of Cardiology, Beijing Friendship Hospital, Capital Medical University, Beijing, China.

Department of Cardiology, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.

出版信息

J Cell Physiol. 2019 Aug;234(8):13878-13893. doi: 10.1002/jcp.28070. Epub 2019 Feb 5.

DOI:10.1002/jcp.28070
PMID:30720220
Abstract

Exosomes extracted from mesenchymal stem cells (MSCs) was reported to reduce myocardial ischemia/reperfusion damage. Besides, stromal-derived factor 1 (SDF1a) functions as cardiac repair after myocardial infarction (MI). Therefore, the present study aims to identify whether exosomes (Exo) released from SDF1-overexpressing MSCs display a beneficial effect on ischemic myocardial infarction. Initially, a gain-of-function study was performed to investigate the function of SDF1 in ischemic myocardial cells and cardiac endothelial cells. Coculture experiments were performed to measure potential exosomic transfer of SDF1 from MSCs to ischemic myocardial cells and cardiac endothelial cells. During the coculture experiments, exosome secretion was disrupted by neutral sphingomyelinase inhibitor GW4869 and upregulated exosomal SDF1 using SDF1 plasmid. Effects of Exo-SDF1 on cardiac function in MI mice were investigated in vivo. MSCs suppressed myocardial cell apoptosis and promoted microvascular regeneration of endothelial cells through secretion of exosomes. The addition of GW4869 led to increased apoptotic capacity of myocardial cells, decreased microvascular formation ability of endothelial cells, enhanced autophagy ability, and elevated Beclin-1 level as well as ratio of LC3II/LC3I. Overexpression of SDF1 and Exo-SDF1 inhibited apoptosis and autophagy of myocardial cells, but promoted tube formation of endothelial cells. The interference of PI3K signaling pathway promoted apoptosis and autophagy of myocardial cells, but inhibited tube formation of endothelial cells. SDF1 activated the PI3K signaling pathway. Exo-SDF1 protected cardiac function of MI mice and inhibited myocardial tissue damage. This study provided evidence that SDF1 overexpression in MSCs-derived exosomes inhibited autophagy of ischemic myocardial cells and promoted microvascular production of endothelial cells.

摘要

从间充质干细胞(MSCs)中提取的外泌体被报道可减轻心肌缺血/再灌注损伤。此外,基质衍生因子 1(SDF1a)在心肌梗死后发挥心脏修复作用。因此,本研究旨在确定 SDF1 过表达的 MSC 释放的外泌体是否对缺血性心肌梗死具有有益作用。首先,进行了一项功能获得研究,以研究 SDF1 在缺血性心肌细胞和心脏内皮细胞中的功能。进行共培养实验以测量 SDF1 从 MSC 到缺血性心肌细胞和心脏内皮细胞的潜在外泌体转移。在共培养实验中,通过中性鞘磷脂酶抑制剂 GW4869 破坏外泌体分泌,并使用 SDF1 质粒上调外泌体 SDF1。体内研究了 Exo-SDF1 对 MI 小鼠心功能的影响。MSCs 通过分泌外泌体抑制心肌细胞凋亡并促进内皮细胞微血管再生。添加 GW4869 导致心肌细胞凋亡能力增加、内皮细胞微血管形成能力降低、自噬能力增强以及 Beclin-1 水平和 LC3II/LC3I 比值升高。SDF1 的过表达和 Exo-SDF1 抑制了心肌细胞的凋亡和自噬,但促进了内皮细胞的管形成。PI3K 信号通路的干扰促进了心肌细胞的凋亡和自噬,但抑制了内皮细胞的管形成。SDF1 激活了 PI3K 信号通路。Exo-SDF1 保护 MI 小鼠的心功能并抑制心肌组织损伤。本研究提供的证据表明,MSC 来源的外泌体中 SDF1 的过表达抑制了缺血性心肌细胞的自噬并促进了内皮细胞的微血管生成。

相似文献

1
Exosomes derived from SDF1-overexpressing mesenchymal stem cells inhibit ischemic myocardial cell apoptosis and promote cardiac endothelial microvascular regeneration in mice with myocardial infarction.SDF1 过表达间充质干细胞衍生的外泌体抑制心肌梗死后小鼠缺血心肌细胞凋亡并促进心脏内皮微血管再生。
J Cell Physiol. 2019 Aug;234(8):13878-13893. doi: 10.1002/jcp.28070. Epub 2019 Feb 5.
2
Astragaloside IV increases PDHA1 in mesenchymal stem cell exosomes to treat myocardial infarction.黄芪甲苷IV通过增加间充质干细胞外泌体中的PDHA1来治疗心肌梗死。
Sci Rep. 2025 Jul 15;15(1):25461. doi: 10.1038/s41598-025-08628-5.
3
Myocardial infarction serum preconditioning bone marrow mesenchymal stem cell-derived exosomes enhance anti-fibrosis in rat myocardial infarction hearts.心肌梗死血清预处理的骨髓间充质干细胞来源的外泌体增强大鼠心肌梗死心脏的抗纤维化作用。
Mol Cell Biochem. 2025 Apr 1. doi: 10.1007/s11010-025-05273-4.
4
Inhalable Stem Cell Exosomes Promote Heart Repair After Myocardial Infarction.可吸入干细胞外泌体促进心肌梗死后的心脏修复。
Circulation. 2024 Aug 27;150(9):710-723. doi: 10.1161/CIRCULATIONAHA.123.065005. Epub 2024 Aug 26.
5
Exosomal SPRY4 from adipogenic BMSCs impairs angiogenesis via the PTPRB/TIE2/PI3K axis in Steroid-induced osteonecrosis of the femoral head.来自成脂骨髓间充质干细胞的外泌体SPRY4通过PTPRB/TIE2/PI3K轴损害激素性股骨头坏死中的血管生成。
Stem Cell Res Ther. 2025 Jul 15;16(1):375. doi: 10.1186/s13287-025-04505-0.
6
Ultrasound-triggered targeted delivery of engineered ADSCs-derived exosomes with high SDF-1α levels to promote cardiac repair following myocardial infarction.超声触发的具有高SDF-1α水平的工程化脂肪来源干细胞衍生外泌体的靶向递送,以促进心肌梗死后的心脏修复。
Int J Pharm. 2025 Aug 20;681:125786. doi: 10.1016/j.ijpharm.2025.125786. Epub 2025 Jun 1.
7
Hypoxic mesenchymal stem cell-derived exosomes promote bone fracture healing by the transfer of miR-126.低氧骨髓间充质干细胞来源的外泌体通过转移 miR-126 促进骨骨折愈合。
Acta Biomater. 2020 Feb;103:196-212. doi: 10.1016/j.actbio.2019.12.020. Epub 2019 Dec 17.
8
RETRACTION: Exosomes Derived From SDF1-Overexpressing Mesenchymal Stem Cells Inhibit Ischemic Myocardial Cell Apoptosis and Promote Cardiac Endothelial Microvascular Regeneration in Mice With Myocardial Infarction.撤稿声明:源自过表达SDF1的间充质干细胞的外泌体抑制心肌梗死小鼠缺血心肌细胞凋亡并促进心脏内皮微血管再生
J Cell Physiol. 2025 Jul;240(7):e70076. doi: 10.1002/jcp.70076.
9
Human umbilical cord mesenchymal stem cell-derived exosomes combined with mouse nerve growth factor can more effectively ameliorate the motor disorder and brain pathological injury in mice with cerebral palsy.人脐带间充质干细胞来源的外泌体联合小鼠神经生长因子能更有效地改善脑瘫小鼠的运动障碍和脑病理损伤。
Adv Clin Exp Med. 2025 Jun;34(6):911-923. doi: 10.17219/acem/192773.
10
BONE MARROW MESENCHYMAL STROMAL CELL-DERIVED EXOSOMAL NRF2 AMELIORATES CEREBRAL ISCHEMIA-REPERFUSION INJURY BY TRANSCRIPTIONALLY ACTIVATING LIN28A.骨髓间充质基质细胞衍生的外泌体 NRF2 通过转录激活 LIN28A 减轻脑缺血再灌注损伤。
Shock. 2024 Jul 1;62(1):85-94. doi: 10.1097/SHK.0000000000002348. Epub 2024 Mar 25.

引用本文的文献

1
The Molecular Dynamics of Extracellular Vesicles and their Protein Corona in the Secretomes of Stem Cells.干细胞分泌组中细胞外囊泡及其蛋白质冠的分子动力学
Stem Cell Rev Rep. 2025 Aug 23. doi: 10.1007/s12015-025-10961-1.
2
Diabetes-preventive molecular mechanisms of breast versus formula feeding: new insights into the impact of milk on stem cell Wnt signaling.母乳喂养与配方奶喂养预防糖尿病的分子机制:牛奶对干细胞Wnt信号传导影响的新见解
Front Nutr. 2025 Jul 29;12:1652297. doi: 10.3389/fnut.2025.1652297. eCollection 2025.
3
Extracellular vesicles: molecular messengers and new therapeutic targets in acute myocardial infarction.
细胞外囊泡:急性心肌梗死中的分子信使和新治疗靶点
Front Immunol. 2025 Jun 26;16:1598407. doi: 10.3389/fimmu.2025.1598407. eCollection 2025.
4
Stem cell-derived exosome delivery systems for treating atherosclerosis: The new frontier of stem cell therapy.用于治疗动脉粥样硬化的干细胞衍生外泌体递送系统:干细胞治疗的新前沿。
Mater Today Bio. 2024 Dec 30;30:101440. doi: 10.1016/j.mtbio.2024.101440. eCollection 2025 Feb.
5
Stromal Cell Derived Factor-1 Promotes Hepatic Insulin Resistance via Inhibiting Hepatocyte Lipophagy.基质细胞衍生因子-1通过抑制肝细胞脂质自噬促进肝脏胰岛素抵抗。
J Cell Mol Med. 2025 Jan;29(2):e70352. doi: 10.1111/jcmm.70352.
6
Mesenchymal Stem Cell-Derived Extracellular Vesicles for Regenerative Applications and Radiotherapy.用于再生应用和放射治疗的间充质干细胞衍生细胞外囊泡
Cell Transplant. 2025 Jan-Dec;34:9636897241311019. doi: 10.1177/09636897241311019.
7
The Potential of Mesenchymal Stem Cell-Derived Exosomes in Cardiac Repair.间充质干细胞衍生外泌体在心脏修复中的潜力
Int J Mol Sci. 2024 Dec 17;25(24):13494. doi: 10.3390/ijms252413494.
8
Cardiac cells and mesenchymal stem cells derived extracellular vesicles: a potential therapeutic strategy for myocardial infarction.心脏细胞和间充质干细胞衍生的细胞外囊泡:一种心肌梗死的潜在治疗策略。
Front Cardiovasc Med. 2024 Dec 18;11:1493290. doi: 10.3389/fcvm.2024.1493290. eCollection 2024.
9
Extracellular vesicle therapeutics for cardiac repair.用于心脏修复的细胞外囊泡疗法。
J Mol Cell Cardiol. 2025 Feb;199:12-32. doi: 10.1016/j.yjmcc.2024.11.005. Epub 2024 Nov 26.
10
Recent Insights into Endogenous Mammalian Cardiac Regeneration Post-Myocardial Infarction.心肌梗死后内源性哺乳动物心脏再生的最新见解。
Int J Mol Sci. 2024 Nov 1;25(21):11747. doi: 10.3390/ijms252111747.